PDE10-PYRIMIDININHIBITOREN
European patent · EP2748151 · In force
Register entry
- Publication number
- EP2748151
- Application number
- EP12826375
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 20, 2012
- Published
- Jul 2, 2014
- Granted
- Mar 16, 2016
- Protection ends at the latest
- Aug 19, 2032
- Next annual fee due
- Aug 31, 2026
- IPC classes
- C07D 401/12 (2006.01)C07D 401/14 (2006.01)C07D 405/14 (2006.01)C07D 417/14 (2006.01)C07D 487/04 (2006.01)A61K 31/506 (2006.01)A61P 25/18 (2006.01)
- Priority
- US 201161527392 P 25.08.2011
- PCT application
- PCT/US2012/051522 20.08.2012
- PCT publication
- WO2013/028590 28.02.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2025
Change
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Change
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Aug 30, 2022
Merged
- Owner
- Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA → MERCK SHARP & DOHME LLC., 126 East Lincoln Avenue, Rahway, New Jersey 07065, USA
Published in Swissreg on 30.08.2022
- Apr 6, 2016
Agent entered
- Representative
- Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich
Published in Swissreg on 06.04.2016
- Mar 16, 2016
Granted
Published in Swissreg on 16.03.2016
Parties
Holder
Inventor
West Point Pennsylvania 19486, US
West Point Pennsylvania 19486, US
West Point Pennsylvania 19486, US
West Point Pennsylvania 19486, US
West Point Pennsylvania 19486, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.